Light as a Weapon: Redefining Cancer Care with Photodynamic Therapy

Area of Science:

• Oncology
• Immunotherapy
• Nanotechnology

Background:

• Photodynamic therapy (PDT) has significantly evolved, becoming a versatile cancer treatment.
• Advances in photosensitizer design, nanotechnology, and immunotherapy have driven PDT's progress.
• PDT is increasingly recognized for its immunomodulatory capabilities, synergizing with other treatments.

Purpose of the Study:

• To critically evaluate recent advances in PDT for cancer treatment.
• To identify and discuss existing bottlenecks and challenges in PDT implementation.
• To outline the potential of PDT in precision oncology and immunotherapy.

Main Methods:

• Review of recent literature on photosensitizer design, nanocarrier systems, and innovative light sources for PDT.
• Analysis of PDT's role in modulating the tumor immune microenvironment.
• Evaluation of clinical data and challenges related to PDT standardization and combination therapies.

Main Results:

• Development of smarter photosensitizers with improved selectivity and penetration.
• Enhanced drug delivery and theranostic potential through nanocarrier systems.
• Emerging applications of PDT in combination with immunotherapy, such as immune checkpoint blockade.

Conclusions:

• PDT has transitioned from a local cytotoxic therapy to a potent immunomodulatory platform.
• Overcoming challenges in dosimetry, hypoxia, nanocarrier safety, and clinical validation is crucial.
• PDT holds significant promise as a central component of precision oncology and next-generation immunotherapy.